XML 72 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Operating activities:    
Net (loss) income $ (4,105) $ 10,203
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and Amortization 19,350 14,919
Amortization of deferred gain 133 (356)
Amortization of deferred financing costs and debt discount 4,621 508
Loss on sale of fixed assets 409 111
Unrealized loss on debt conversion option 15,597  
Unrealized (gains) losses on commodity hedges (192) 1,571
Equity in earnings of joint venture (6,099) (8,958)
Dividends from joint venture 1,828 2,245
Deferred tax benefit 542 (2,294)
Share-based compensation expense 3,061 3,047
Excess tax benefits from share-based payment arrangements (63) (145)
Increase (decrease) from changes in, net of acquisition:    
Accounts receivable 11,877 (41,366)
Inventories (82,616) (58,323)
Prepaid expenses and other current assets (6,047) (2,458)
Other assets (2,293) (508)
Prepaid pension costs (1,357) (1,381)
Accounts payable 16,943 42,367
Income taxes payable and receivable 1,798 7,771
Accrued liabilities 13,852 (4,133)
Postretirement benefit obligations and other liabilities (168) (404)
Net cash used in operating activities (12,929) (37,584)
Investing activities:    
Capital expenditures (8,991) (8,236)
Proceeds from sale of fixed assets 22 217
Insurance proceeds   573
Net cash used in investing activities (8,969) (7,446)
Financing activities:    
Short-term borrowings (repayments), net 500 33,571
Net (repayments) borrowings on previously existing revolving lines of credit   1,618
Proceeds from long-term debt, including new revolving credit facility 576,477  
Repayments of long-term debt, including new revolving credit facility (564,273) (300)
Payment of debt issue costs (1,503)  
Excess tax benefits (deficiencies) from share-based payment arrangements 63 145
Exercise of stock options 104 240
Net cash from financing activities 11,368 35,274
Effect of exchange rate changes on cash and cash equivalents (6) (1,059)
Net decrease in cash and cash equivalents (10,536) (10,815)
Cash and cash equivalents - beginning of year 30,524 36,716
Cash and cash equivalents - end of period $ 19,988 $ 25,901